Senior Strategic Transactions Lead, APEX

The role

This person will execute transactions across the Flagship ecosystem including licensing, partnerships, M&A, and venture financings. They will partner with business leaders to drive strategic structuring and negotiation of complex deals.

What you will do

• Own and drive the execution of transactions including licensing, collaboration, financing, partnership, joint venture, M&A, and other strategic transactions.
• Coordinate with colleagues and external advisors to facilitate decision-making.
• Drive the design and strategic structuring of complex transactions.
• Drive the negotiation of transaction terms and completion of processes.
• Manage multiple transactions simultaneously in a fast-paced environment.
• Stay ahead of industry trends, regulations, and legal developments.
• Contribute to developing and implementing best practices, templates, and playbooks.
• Direct external law firm partners and advisors to manage negotiations and legal costs.
• Counsel internal stakeholders on legal interpretations, risk management and compliance.

Required qualifications

• J.D. from a top-tier law school, or equivalent graduate school degree in a relevant field
• 10+ years of experience in complex life sciences transactions, including top-tier law firm experience or top-tier investment bank, consulting firm or investment firm
• Deep expertise in corporate transactions and financings, including pharmaceutical collaborations and licensing agreements
• Proven ability to lead negotiations on complex, high-value deals in the biotech or pharmaceutical industry
• Excellent executive presence, communication, leadership, and problem-solving skills

Nice to have

• previous in-house pharma experience

Benefits

• healthcare coverage
• annual incentive program
• retirement benefits
• a broad range of other benefits

About the company

Flagship Pioneering invents and builds companies that change the world by uniting life science innovation, company creation, and capital investment. The team includes scientists, entrepreneurial leaders, and professional capital managers.